Skip to main content
Dr. Timothy Hanna

Dr. Timothy Hanna appointed Clinical Teachers’ Association of Queen’s (CTAQ) Chair in Applied Health Economics & Policy

Dean Jane Philpott has appointed Dr. Timothy Hanna as the Clinical Teachers’ Association of Queen’s (CTAQ) Chair in Applied Health Economics and Policy effective November 1, 2023 until October 31, 2028.  

Dr. Hanna’s role as CTAQ Chair will provide intellectual leadership nationally and internationally in the field of applied health economics and policy, conduct high quality research in applied health economics and policy, and enable scholarship by CTAQ physicians in applied health economics and policy. An endowed position, the CTAQ Chair was established through the generous support of the Southeastern Ontario Academic Medical Organization (SEAMO). 

"We are pleased to congratulate Dr. Timothy Hanna on his appointment as the CTAQ Chair in Applied Health Economics and Policy,” said Dr. Tarit Saha, President of CTAQ. “In this role, Dr. Hanna will engage in research that supports the development of equitable access to healthcare in southeastern Ontario and beyond." 

Dr. Hanna is a primary investigator, Division of Cancer Care and Epidemiology, at the Queen’s Cancer Research Institute, and an Associate Professor in the Department of Oncology. He is cross-appointed to the Department of Public Health Sciences and the Department of Medicine. 

Dr. Hanna is a radiation oncologist and clinician-scientist at the Cancer Centre of Southeastern Ontario at the Kingston Health Sciences Centre, a clinician-scientist at the Ontario Institute for Cancer Research, the Radiation Oncology Clinical Quality Lead for the Ontario Health Cancer Care Ontario Radiation Treatment Program, and a senior adjunct scientist at ICES (formerly the Institute for Clinical Evaluative Sciences). 

Dr. Hanna received his PhD and Fellowship training at the Collaboration for Cancer Outcomes Research and Evaluation (CCORE) at Liverpool Hospital in Sydney, Australia (2010-2012) where he developed models of population benefit of optimal radiotherapy utilization as part of his PhD thesis. Prior to this, he trained at Queen’s in Radiation Oncology and completed an MSc that focused on barriers to access to radiation and its impact on cancer outcomes. He obtained his MD at the University of Toronto.  

Multiple themes in Dr. Hanna’s ongoing research program align with his mandate as CTAQ Chair. Dr. Hanna’s work focuses on health services research in oncology, with three translational streams: quality of care, value of care, and access to care. His value of care research touches on health technology assessment in the real-world, particularly for novel therapies (e.g., radiotherapy, omics-driven personalized medicine, and immunotherapy). His research interests also involve global health, and global oncology.  

Dr. Hanna has led major, high-impact work, including research on treatment delay and cancer mortality published in the BMJ in 2020, and a cancer treatment prioritization framework that was the most accessed article in Nature Reviews Clinical Oncology in 2020 and strongly 

influenced Ontario’s systemic therapy and radiation therapy prioritization schemes during the pandemic.  

Dr. Hanna’s current leadership roles at Queen’s include Chair of the Competence Committee, Queen’s University Radiation Oncology Residency Training Program, and Chair of the Queen’s University Skin Cancer Site Group. In 2020-21, he received the Mihran and Mary Basmajian Award for Excellence in Health Research. 

Please join Dean Philpott in congratulating Dr. Hanna on his appointment.    

Related topics